PFE - PFIZER INC
26.62
0.040 0.150%
Share volume: 30,790,196
Last Updated: 03-04-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.72%
PREVIOUS CLOSE
CHG
CHG%
$26.58
0.04
0.00%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-29-2024 | 12-31-2024 | 03-30-2025 | 06-29-2025 | 09-28-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-08-2024 | 08-05-2024 | 11-04-2024 | 02-27-2025 | 05-05-2025 | 08-05-2025 | 11-04-2025 | 02-26-2026 | |
| Total revenue | 14.878 B | 13.283 B | 17.702 B | 17.763 B | 13.715 B | 14.653 B | 16.654 B | 17.557 B | |
| Cost of revenue | 3.379 B | 3.300 B | 5.263 B | 5.909 B | 2.845 B | 3.778 B | 4.172 B | 5.272 B | |
| Gross profit | 11.499 B | 9.983 B | 12.439 B | 11.854 B | 10.870 B | 10.875 B | 12.482 B | 12.285 B | |
| -13.18% | 24.60% | -4.70% | -8.30% | 0.05% | 14.78% | -1.58% | |||
| Operating expenses | 5.988 B | 6.419 B | 5.855 B | 7.398 B | 5.243 B | 5.899 B | 7.122 B | 7.580 B | |
| Selling general and admin | 3.495 B | 3.717 B | 3.244 B | 4.274 B | 3.031 B | 3.415 B | 3.186 B | 4.162 B | |
| Research and development | 2.493 B | 2.702 B | 2.611 B | 3.124 B | 2.212 B | 2.484 B | 3.936 B | 3.418 B | |
| Total expenses | 10.675 B | 8.980 B | 7.480 B | 9.507 B | 7.132 B | 7.092 B | 8.631 B | 9.413 B | |
| -15.88% | -16.70% | 27.10% | -24.98% | -0.56% | 21.70% | 9.06% | |||
| Operating income | 4.203 B | 1.003 B | 4.959 B | 2.347 B | 3.738 B | 3.783 B | 3.851 B | 2.872 B | |
| Ebit | 4.115 B | -104.000 M | 4.716 B | -11.000 M | 2.785 B | 3.044 B | 3.334 B | -1.643 B | |
| Pretax income | 3.421 B | -103.000 M | 4.715 B | -10.000 M | 2.785 B | 3.044 B | 3.334 B | -1.643 B | |
| -103.01% | -4,677.67% | -100.21% | -27,950.00% | 9.30% | 9.53% | -149.28% | |||
| Income tax | 293.000 M | -134.000 M | 234.000 M | -421.000 M | -189.000 M | 141.000 M | -216.000 M | -2.000 M | |
| Net income basic | 3.115 B | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| -100.00% | |||||||||
| Net income | 3.115 B | 48.000 M | 4.473 B | 418.000 M | 2.973 B | 2.928 B | 3.550 B | -1.639 B | |
| -98.46% | 9,218.75% | -90.66% | 611.24% | -1.51% | 21.24% | -146.17% |